RASAGILINE FOR PARKINSONS DISEASE MODIFICATION

• 收藏
• 分享

专利权人:

TEVA PHARMACEUTICAL INDUSTRIES LTD.

发明人:

LEVY, RUTH,EYAL, ELI,GOREN, TAMAR,OREN, SHEILA,SAYAG, NAIM,WEISS, YONATAN,BEN-AMI, MIRI

申请号：

NZ58944509

公开号：

NZ589445A

申请日:

2009.06.12

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

Disclosed herein is the use of rasagiline, or a pharmaceutically acceptable salt of rasagiline at a dose of 1 mg of rasagiline per day in the manufacture of a medicament to reduce the rate of progression of Parkinsons disease in an early stage Parkinsons disease patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/